Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Exchange Rate Effect (2018 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Exchange Rate Effect for 8 consecutive years, with -$1.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Exchange Rate Effect fell 173.69% year-over-year to -$1.2 million, compared with a TTM value of -$755000.0 through Sep 2025, down 131.78%, and an annual FY2024 reading of -$694000.0, down 151.56% over the prior year.
  • Exchange Rate Effect was -$1.2 million for Q3 2025 at Bicycle Therapeutics, down from $1.8 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $3.6 million in Q4 2022 and bottomed at -$2.6 million in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$34368.4, with a median of -$174000.0 recorded in 2021.
  • Peak annual rise in Exchange Rate Effect hit 59333.33% in 2022, while the deepest fall reached 743.1% in 2022.
  • Year by year, Exchange Rate Effect stood at -$6000.0 in 2021, then soared by 59333.33% to $3.6 million in 2022, then plummeted by 63.73% to $1.3 million in 2023, then tumbled by 238.17% to -$1.8 million in 2024, then grew by 29.87% to -$1.2 million in 2025.
  • Business Quant data shows Exchange Rate Effect for BCYC at -$1.2 million in Q3 2025, $1.8 million in Q2 2025, and $468000.0 in Q1 2025.